-
4-Hydroxytamoxifen: Practical Workflow Guide
2026-09-24
4-Hydroxytamoxifen (SKU B6167) provides a DMSO-soluble estrogen receptor modulator for controlled cell and animal research workflows. It may suit breast cancer research, prostate cancer research, apoptosis assay development, and cardiac myocyte calcium handling studies, but it is not appropriate for protocols requiring direct water- or ethanol-based stocks without separate formulation validation.
-
Imatinib in Gastric Cancer Assembloid Workflows
2026-09-23
Use Imatinib (STI571) to probe PDGFR, c-Kit, and Abl signaling in patient-derived gastric cancer models—not as a result already established by assembloid studies, but as a targeted experimental question. Pair short-term phospho-signaling readouts with longer-term viability assays to test whether matched stromal cells alter pathway response.
-
GKT137831 and the Next Frontier of Redox Biology
2026-09-23
GKT137831 offers a source-proximal way to interrogate Nox1/Nox4-driven oxidative signaling, while emerging ferroptosis biology highlights the importance of membrane fate. This article outlines a translational strategy connecting redox control, vascular remodeling, fibrosis, and testable ferroptosis hypotheses.
-
Abiraterone Acetate in Patient-Derived 3D Models
2026-09-22
A translational framework for using Abiraterone acetate as a CYP17 inhibitor in patient-derived prostate cancer spheroids, with emphasis on androgen biology, assay context, compound handling, and the limits of extrapolating organ-confined models to castration-resistant disease.
-
Estradiol Benzoate: Reliable ERα Assays
2026-09-22
Learn how Estradiol Benzoate, SKU B1941, can improve consistency in estrogen receptor signaling research, hormone receptor binding assays, and cell-based viability or proliferation workflows. This scenario-driven guide covers solubility, stock preparation, controls, interpretation, and product-selection criteria using documented specifications.
-
Targeted Amikacin Delivery into Mycobacterial Granulomas
2026-09-21
The reference study developed a dendritic-cell delivery strategy that transported fluorescently labeled amikacin into granulomas in mice infected with Mycobacterium avium. Its main contribution is proof of organism-directed localization without detectable systemic amikacin, while preserving antibacterial activity and avoiding increased MCP-1 or CCR2 inflammatory markers.
-
Omeprazole (A2845): Practical Research Guide
2026-09-21
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research, biochemical inhibition assays, and related antiulcer activity study workflows. This dossier-based guidance addresses handling, solubility, assay setup, and quality control; the product is for scientific research only and not for diagnostic or medical use.
-
rTMS Activates Cx3cl1-Cx3cr1 Signaling in AD
2026-09-20
This study identifies a cellular pathway through which repetitive transcranial magnetic stimulation may improve Alzheimer’s disease-related pathology: activation of GABAergic neurons increases Cx3cl1 signaling and promotes Cx3cr1-associated microglial clearance of amyloid-β. Its combination of single-cell transcriptomics, plaque analysis, microglial phenotyping, and cognitive assessment provides a mechanistic framework for evaluating non-invasive neuromodulation in Alzheimer’s disease models.
-
Omeprazole (A2845): Practical Research Guide
2026-09-19
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research, assay development, and antiulcer activity studies. This guide covers dossier-based parameters, solution handling, QC, and interpretation boundaries; the material is for research use only and not for diagnostic, therapeutic, or medical applications.
-
Ganetespib (STA-9090) Assay Guide
2026-09-18
A scenario-based guide to using Ganetespib (STA-9090), SKU A4385, in cell viability, proliferation, and cytotoxicity workflows. It connects Hsp90 biology with practical stock preparation, assay controls, dose selection, orthogonal validation, and evidence-based product evaluation.
-
Methoxy-X04 for Amyloid Imaging Workflows
2026-09-18
Methoxy-X04 combines brain permeability with nanomolar amyloid-β fibril binding, enabling rapid plaque, oligomer, and cerebrovascular amyloid readouts in Alzheimer’s disease models. This guide shows how to turn the probe into a reproducible workflow for testing exercise-linked extracellular vesicle mechanisms and microglial plaque clearance.
-
CUDC-907: Practical PI3K/HDAC Assay Guide
2026-09-17
CUDC-907 (SKU A4097) provides a research starting point for coordinated investigation of PI3K/AKT signaling and histone deacetylase activity in cancer cell assays. This dossier-driven guide covers preparation, controls, pathway readouts, and limitations; it is not a diagnostic, therapeutic, or clinical-use protocol.
-
Amyloid Beta-Peptide (1-40) (human): Assay Guide
2026-09-17
This scenario-based guide helps researchers control peptide preparation, solvent effects, aggregation state, and assay interpretation when using Amyloid Beta-Peptide (1-40) (human), SKU A1124. It connects product specifications with current evidence on monomeric Aβ signaling and offers practical criteria for selecting an Alzheimer's disease research peptide.
-
Methoxy-X04 for Amyloid Imaging Workflows
2026-09-16
Methoxy-X04 converts amyloid pathology into a spatially resolved fluorescent readout for plaque, oligomer, and vascular studies. This guide connects practical assay design with the rTMS–microglial clearance findings reported in a 5xFAD model, while separating validated product specifications from workflow recommendations.
-
ALDH2 Activation Delays Pressure-Overload Heart Failure
2026-09-16
The reference study identifies ALDH2 as a regulator of cardiomyocyte proliferation, showing that its activation extends the early postnatal proliferative window and improves outcomes in adult mice exposed to ventricular pressure overload. Its use of Alda-1 links aldehyde metabolism with cardiac regeneration and provides a mechanistic framework for cardiac ischemia research and related cardioprotection studies.